All these results documented that miR-214 directly targeted PTEN, leading the degradation of PTEN mRNA, which in turn, activated PI3K/Akt pathway and promoted tumor radioresistant of ovarian cancer cells. The gene discussed is PTEN; the disease is ovarian cancer.